Keene & Associates’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $851K | Buy |
10,904
+730
| +7% | +$57K | 0.68% | 36 |
|
|
2024
Q3 | $818K | Buy |
10,174
+298
| +3% | +$24K | 0.62% | 37 |
|
|
2024
Q2 | $817K | Sell |
9,876
-123
| -1% | -$10.2K | 0.67% | 35 |
|
|
2024
Q1 | $853K | Buy |
9,999
+1,219
| +14% | +$104K | 0.64% | 37 |
|
|
2023
Q4 | $751K | Buy |
8,780
+268
| +3% | +$22.9K | 0.62% | 38 |
|
|
2023
Q3 | $763K | Buy |
8,512
+250
| +3% | +$22.4K | 0.61% | 38 |
|
|
2023
Q2 | $703K | Sell |
8,262
-594
| -7% | -$50.6K | 0.55% | 35 |
|
|
2023
Q1 | $733K | Buy |
8,856
+72
| +0.8% | +$5.96K | 0.57% | 35 |
|
|
2022
Q4 | $691K | Sell |
8,784
-1,390
| -14% | -$109K | 0.62% | 34 |
|
|
2022
Q3 | $753K | Sell |
10,174
-1,899
| -16% | -$141K | 0.69% | 34 |
|
|
2022
Q2 | $787K | Sell |
12,073
-1,461
| -11% | -$95.2K | 0.74% | 32 |
|
|
2022
Q1 | $856K | Buy |
13,534
+1,814
| +15% | +$115K | 0.7% | 35 |
|
|
2021
Q4 | $622K | Buy |
+11,720
| New | +$622K | 0.54% | 38 |
|